Drugs / CD7 CAR-γδT cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07120607 | Aug 2025 → Dec 2026 expected | leukemia | Anhui Provincial Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD7 CAR-γδT cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07120607 ↗ |
| Known as | QH106 | “CD7 CAR-γδT cell（QH106）” NCT07120607 ↗ |
| Modality | Cell therapy | “Allogenic CD7 CAR-γδT cell” NCT07120607 ↗ |
| Route | Intravenous | “Intravenous on day0” NCT07120607 ↗ |
| Target | CD7 | “Targeted CD7 cell therapies” NCT07120607 ↗ |